The Advisory Committee on Immunization Practices’ (ACIP) recommend HEPLISAV-B™ for use among individuals age 18 years and older to prevent hepatitis B infection (HBV).
General News
The NYC Health Department recently released the 2018 version of City Health Information (CHI): Diagnosing & Managing Hep C providing guidance to Primary Care Providers in hepatitis C screening, management and treatment.
Now is the time to submit your abstract to become part of the 2018 NYC Viral Hepatitis Research Symposium! The primary focus of the meeting is on addressing viral hepatitis in special populations. Authors are encouraged to submit abstracts on their research and health care evalua...
The NYC Health Department in collaboration with the Northeast/Caribbean AIDS Education and Training Center (AETC) Program hosted a symposium focusing on Eliminating Hep C in People Living with HIV in New York City.
More than 60 organizations, including NVHR, signed onto a letter urging the Trump administration to invest in the Department of Health & Human Services Viral Hepatitis Action Plan
The American College of Physicians' High Value Care Task Force and the Centers for Disease Control and Prevention developed this article to present best practice statements for hepatitis B vaccination, screening, and linkage to care.
On October 16, 2014, the fee-for-service (FFS) pharmacy program implemented clinical criteria for Hepatitis C Virus (HCV) drug therapy, as was recommended by the Drug Utilization Review Board (DURB) at the September 18, 2014 meeting. Included in this criteria were the following ...
Learn about FREE VIRAL HEPATITIS TRAINING opportunities throughout New York State.
Learn about key clinical updates in Hepatitis C presented at recent conferences.
The researchers found anti-HCV antibody in 372 of 4,989 participants (7.5%) with completed results. The confirmatory test showed HCV RNA positive in 196 individuals—38 of which (19.2%) of which were undiagnosed. There was also a substantial number of coinfections in the cohort....
